NED Medical

Norwell, United States Founded: 2022 • Age: 4 yrs
Embolisation-based technology for cancer treatment is developed.
Annual revenue - Latest available
Total funding $9.8M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About NED Medical

NED Medical is a company based in Norwell (United States) founded in 2022 by Andy Thoreson and Richard Yazbeck. NED Medical has raised $9.8 million across 2 funding rounds. NED Medical offers products and services including CombiSphere. NED Medical operates in a competitive market with competitors including MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, NEXTBIOMEDICAL and MegaPro Biomedical, among others.

  • Headquarter Norwell, United States
  • Founders Andy Thoreson, Richard Yazbeck
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ned Medical Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $9.8 M (USD)

    in 2 rounds

  • Latest Funding Round
    $8 M (USD), Series A

    Jan 20, 2026

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NED Medical

NED Medical offers a comprehensive portfolio of products and services, including CombiSphere.

Product name locked
Category locked
Primary

Y90 therapy for liver cancer with optimized features for improved tumor coverage.

Funding Insights of NED Medical

NED Medical has successfully raised a total of $9.8M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by NED Medical

Investments
Premium access

Investment portfolio details for NED Medical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NED Medical

Premium access

Detailed financials for NED Medical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ned Medical Comparisons

NED Medical Primary company
Description
Embolisation-based technology for cancer treatment is develo...
Location
Norwell, United States
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for NED Medical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NED Medical

NED Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiNA Therapeutics, Alentis Therapeutics, Hepion Pharmaceuticals, NEXTBIOMEDICAL and MegaPro Biomedical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Small activating RNA therapeutics are developed to restore gene function.
Locked Locked Locked
Therapies for fibrosis, cirrhosis, and liver cancer are developed.
Locked Locked Locked
Provides therapeutics for chronic liver disorder
Locked Locked Locked
Manufacturer of drug and delivery system for wound dressing for gastrointestinal bleeding
Locked Locked Locked
Developer of niche-type nano-drugs for cancer
Premium access

Detailed competitors of NED Medical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ned Medical

Premium access

Complete news archive for NED Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NED Medical

NED Medical was founded in 2022 and raised its 1st funding round 1 year after it was founded.

NED Medical is headquartered in Norwell, United States. It is registered at Norwell, Massachusetts, United States.

Richard Yazbeck is the current CEO of NED Medical. They have also founded this company.

NED Medical is a funded company, having raised a total of $9.8M across 2 funding rounds to date.

Developer of embolisation-based technology for cancer treatment. It offers combisphere which is a radioembolic microsphere that reduces and eliminates the side effects and toxicities of chemotherapies for treating liver tumors.

NED Medical's top competitors include MiNA Therapeutics, Alentis Therapeutics and Hepion Pharmaceuticals.

NED Medical offers CombiSphere.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available